New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Seres Therapeutics, Inc.

MCRB

Healthcare Biotechnology

Seres Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $789,000.00, down 99.4% from fiscal 2023.

Revenue
+69.0%
EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.24 0.09 −6.77%

After hours trading: 1.25, up 0.81%, last trade Fri 7:35pm Eastern.

Market cap
$13.6M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
n/a
Net debt / EBITDA
0.5×
Payout ratio
—

Seres Therapeutics, Inc. (MCRB) Return on invested capital

Alert me on Return on invested capital

Seres Therapeutics, Inc.'s return on invested capital over the twelve months to Sep 30, 2026 was −1,267.8%, down 1267.8 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from −3,817.9% (fiscal 2015) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.

Return on invested capital, annual

Embed this chart

Annual newest first

Period Return on invested capital Change (points)
FY2025 0.00% 0.00
FY2024 0.00% 0.00
FY2023 0.00% 0.00
FY2022 0.00% 0.00
FY2021 0.00% 0.00
FY2020 0.00% 0.00
FY2019 0.00% 0.00
FY2018 0.00% 0.00
FY2017 0.00% 0.00
FY2016 0.00% 3,817.93

Against its own ten years

Low −3,817.9% High 0.00%
Ten-year median 0.00%
Current reading's percentile 100

Return on invested capital against peers

Company Return on invested capital
ALLR Allarity Therapeutics, Inc. compare 0.00%
ACTU Actuate Therapeutics, Inc. compare 0.00%
ABOS Acumen Pharmaceuticals, Inc. compare 0.00%
BSEM BioStem Technologies, Inc. compare −7.07%
CTXR Citius Pharmaceuticals, Inc. compare −58.7%
BOLT Bolt Biotherapeutics, Inc. compare −154.8%
PLUR Pluri Inc. compare −436.8%
MCRB Seres Therapeutics, Inc. −1,267.8%
NCEL NewcelX Ltd. compare —
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.06%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on MCRB